MacroGenics Statistics
NASDAQ: MGNXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.96-0.02 (-1.01%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MacroGenics by the numbers
MacroGenics has a market capitalization of $125.3 million based on 63.91M shares outstanding. With trailing EPS of $-2.30, MacroGenics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 37.1% below its 50-day average and 43.2% below its 200-day average.
Average daily trading volume is 747.02K shares, or about $1.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MGNX valuation vs. peer median
| Metric | MGNX | Peer median | Difference |
|---|---|---|---|
| Market cap | $125.26M | $119.34M | +5% |
| Avg. volume | 747.02K | 346.13K | +116% |
Peer median across 8 companies: SION, MSLE, ZNTL, ADAG, ALXO, OKUR, IMUX, MENS.
Valuation
- Market cap
- $125.26M
- Price / sales (latest FY)
- 0.84
- EPS (TTM)
- $-2.30
- Shares outstanding
- 63.91M
Price and trading
- Previous close
- 1.98
- Open
- 1.96
- Day range
- 1.90 – 2.08
- 52-week range
- 1.32 – 5.08
- 52-week change
- +40.00%
- Beta
- —
- Volume
- 1.52M
- Average volume
- 747.02K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 125.26M
- Forward Pe
- -1.16
- Eps
- -2.30
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.08
- Week52 Low
- 1.32
- Avg Volume
- 747.02K
- Shares Outstanding
- 63.91M
- Ma50
- 3.12
- Ma200
- 3.45
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -61.42%
- Pct From52w Low
- 48.48%